Healthcare Stock Movers ( PPHM, CTIC, HEB, ACAD, COO)

NEW YORK, September 10, 2012 (MESHPRESS) –  Beststocksdaily.com, an investment community with a  special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Peregrine Pharmaceuticals(NASDAQ PHM) shares climbed 46.58% and closed at $4.50 in the previous trading session. The company announced that interim results from its Phase IIb trial in patients with refractory non-small cell lung cancer showed a statistically significant improvement in overall survival and a doubling of median overall survival in the bavituximab-containing arms, compared to the control arm.

Additionally, Roth Capital restated their buy rating on shares of PPHM and the firm currently has a $5.00 price target on the stock.

Can PPHM Continue To Move Higher? Find Out Here

Cell Therapeutics Inc(NASDAQ:CTIC) shares soared 29.61% and closed at $2.32 in the last trading session. The company’s management will present at the Annual Rodman & Renshaw Global Investment Conference on Tuesday, September 11 at 10:25 a.m. Eastern/ 4:25 p.m. Central European/ 7:25 a.m. Pacific time in the Starlight North room of the Waldorf-Astoria Hotel.

Can CTIC Extend Rally? Find Out Here

Hemispherx BioPharma, Inc(NYSEAMEX:HEB) shares jumped 13% and closed at $0.870 in the previous trading session. The 52 week trading range for the company is $0.17 – $0.95. The shares of the company soared 180% in the last one year. The company is a specialty pharmaceutical engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders.

Can HEB Continue To Move Higher? Find Out Here

ACADIA Pharmaceuticals Inc.(NASDAQ:ACAD) shares increased 9.71% and closed at $1.92 in the last trading session. The company announced the completion of enrollment in its ongoing pivotal Phase III trial with pimavanserin in patients with Parkinson’s disease psychosis (PDP). Top-line results from this trial are expected to be announced by the end of November 2012.

Has ACAD Found The Bottom? Find Out Here

The Cooper Companies, Inc.(NYSE:COO) shares gained 8.49% and closed at $93.33 in the previous trading session. Citigroup restated its Neutral rating on COO and raised its price target from $85.00 to $92.00.

Additionally, the company last week reported third quarter net income of $66.9 million or $1.36 per share, as compared to $44.2 million or $0.90 per share for the year-ago quarter. Adjusted net income for the latest was $71.7 million or $1.45 per share. Net sales rose 8% to $378.19 million from $351.40 million in the same quarter last year. Analysts expected the company to earn $1.29 per share on revenue estimate of $367.59 million for the third quarter.

Can COO Extend Rally? Find Out Here

About Beststocksdaily

Beststocksdaily.com team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily.com instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.

Disclaimer:

The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.

Contact:

beststocksdaily.com

staff@beststocksdaily.com